We found a match
Your institution may have access to this item. Find your institution then sign in to continue.
- Title
Treatment of Benign Prostatic Hyperplasia by Ultrasound-Guided Botulinum Toxin Type A Injection.
- Authors
Ding, Xu-Dong; Chen, Huan-Xian; Xiao, Hong-Qiong; Wang, Wei; Ding, Zhi-Gang; Zhang, Gui-Bin; Fu, Du-Guan
- Abstract
The objective of the study was to determine the efficacy of ultrasound-guided botulinum toxin type A (BTX-A) injection in the treatment of benign prostatic hyperplasia (BPH). In the 32 patients clinically diagnosed with BPH, 200 IU BTX-A was injected into five points at the lateral and middle lobes of the prostate under the guidance of ultrasound using a balloon dilatational device. The international prostate symptom score, quality of life score, maximum flow rate, post-void residual urine volume, prostate-specific antigen, and prostate volume were determined before treatment and at 1, 3, 6, and 12 months after treatment. All clinical symptoms and indicators were remarkably improved 1 month after the treatment and reached the optimal levels at 6 months post-treatment. This improvement of clinical parameters was maintained for a period of at least 1 year. Ultrasound-guided BTX-A injection was found to be safe and effective in the management of BPH.
- Subjects
HYPERPLASIA treatment; BENIGN prostatic hyperplasia; ULTRASONIC imaging; BOTULINUM A toxins; PROSTATE-specific antigen; DIAGNOSIS
- Publication
Cell Biochemistry & Biophysics, 2015, Vol 73, Issue 2, p357
- ISSN
1085-9195
- Publication type
Article
- DOI
10.1007/s12013-015-0606-8